Movicol Apelsin

Macrogol 3350, the active ingredient in Movicol Apelsin, is an osmotic laxative presented as an oral formulation for oral administration. It works by increasing water content in the intestinal lumen, thereby softening stools and facilitating bowel movements, and is indicated for constipation and bowel preparation in adults.

GNH USA supplies Movicol Apelsin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and consistent product quality for global healthcare providers through established distribution networks.

Movicol Apelsin, an osmotic laxative, is used to manage conditions involving reduced bowel motility and to cleanse the colon before procedures.

Constipation: alleviates occasional or chronic constipation by increasing stool water content and promoting regular bowel movements. Bowel preparation: facilitates colon cleansing prior to colonoscopy, sigmoidoscopy or surgical interventions by producing soft, easy‑to‑pass stools. Chronic idiopathic constipation: provides long‑term symptom relief in patients with persistent constipation.

Common Side Effects: - Abdominal bloating: a feeling of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas leading to discomfort. - Nausea: mild to moderate sensation of unease in the stomach. - Diarrhoea: loose, watery stools occurring especially with higher doses. - Abdominal cramps: intermittent cramping pain in the lower abdomen.

Serious or Rare Side Effects: - Severe dehydration: marked loss of body fluids requiring medical attention. - Electrolyte imbalance: abnormal levels of sodium, potassium or chloride that may affect heart rhythm. - Allergic reaction: rash, itching, swelling or difficulty breathing. - Severe abdominal pain: persistent, intense pain that does not resolve. - Rectal bleeding: presence of blood in stool indicating possible mucosal injury.

Before using Movicol Apelsin, consider the following precautions: - Renal function assessment: evaluate kidney status to avoid fluid overload. - Electrolyte monitoring: check serum electrolytes, especially potassium and sodium, during prolonged therapy. - Use in the elderly: start with the lowest effective dose and monitor tolerance. - Contraindication in intestinal obstruction: avoid use if a mechanical blockage is present. - Fluid intake: maintain adequate hydration to reduce risk of dehydration. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Movicol Apelsin may interact with other medicines as follows:

Major Interactions (Avoid): - Concomitant osmotic laxatives: combined use can cause excessive fluid loss and electrolyte disturbances. - Loop diuretics: may amplify the risk of dehydration and electrolyte imbalance.

Moderate Interactions (Monitor Closely): - Digoxin: altered potassium levels can affect digoxin toxicity; monitor serum levels. - Lithium: changes in sodium balance may increase lithium concentrations; adjust dose as needed. - Antacids containing magnesium or aluminium: may reduce the efficacy of the laxative; separate administration times.